US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts
The Economic Times has reported a new India-focused foreign affairs development: “US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts.” The publisher's feed describes the story as follows: US pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market reliance. There are warnings that ensuring patient access to affordable medications should remain paramount. Intellectual Janata Party incl
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.


